------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    A new drug to prevent the rejection of transplanted organs has been successfully used on more than 100 patients at the
    University of Pittsburgh, according to researchers.

Treebanked sentence:
--------------------
    A new drug 0 *T*-2 to prevent the rejection of transplanted organs has been successfully used *-1 on more than 100
    patients at the University of Pittsburgh , according to researchers .

Tree:
-----
    (TOP (S (NP-SBJ-1 (NP (DT A)
                          (JJ new)
                          (NN drug))
                      (SBAR (WHNP-2 (-NONE- 0))
                            (S (NP-SBJ (-NONE- *T*-2))
                               (VP (TO to)
                                   (VP (VB prevent)
                                       (NP (NP (DT the)
                                               (NN rejection))
                                           (PP (IN of)
                                               (NP (JJ transplanted)
                                                   (NNS organs)))))))))
            (VP (VBZ has)
                (VP (VBN been)
                    (ADVP-MNR (RB successfully))
                    (VP (VBN used)
                        (NP (-NONE- *-1))
                        (PP-CLR (IN on)
                                (NP (QP (JJR more)
                                        (IN than)
                                        (CD 100))
                                    (NNS patients)))
                        (PP-LOC (IN at)
                                (NP (NP (DT the)
                                        (NNP University))
                                    (PP (IN of)
                                        (NP (NNP Pittsburgh)))))
                        (, ,)
                        (PP (VBG according)
                            (PP (IN to)
                                (NP (NNS researchers)))))))
            (. .)))

Leaves:
-------
    0   A
    1   new
    2   drug
    3   0
    4   *T*-2
    5   to
    6   prevent
           sense: prevent-v.1
           prop:  prevent.01
            v          * -> 6:0,  prevent
            ARG3       * -> 4:0,  *T*-2 -> 3:0, 0
            ARG1       * -> 7:2,  the rejection of transplanted organs
            LINK-SLC   * -> 0:1,  A new drug
                       * -> 4:0,  *T*-2 -> 3:0, 0
    7   the
    8   rejection
    9   of
    10  transplanted
    11  organs
    12  has
    13  been
    14  successfully
    15  used
           prop:  use.01
            v          * -> 15:0, used
            ARGM-MNR   * -> 14:1, successfully
            ARG1       * -> 16:0, *-1 -> 0:2, A new drug 0 *T*-2 to prevent the rejection of transplanted organs
            ARGM-LOC   * -> 17:1, on more than 100 patients
            ARGM-TMP   * -> 22:1, at the University of Pittsburgh
            LINK-PCR   * -> 16:0, *-1 -> 0:2, A new drug 0 *T*-2 to prevent the rejection of transplanted organs
                       * -> 16:0, *-1 -> 0:2, A new drug 0 *T*-2 to prevent the rejection of transplanted organs
    16  *-1
    17  on
    18  more
           name:  CARDINAL           18-20  more than 100
    19  than
    20  100
    21  patients
    22  at
    23  the
           name:  ORG                23-26  the University of Pittsburgh
    24  University
    25  of
    26  Pittsburgh
    27  ,
    28  according
    29  to
    30  researchers
    31  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    The drug, which is still in the experimental phase, has n't been approved yet by the Food and Drug Admistration, and its
    long-term effects are unknown.

Treebanked sentence:
--------------------
    The drug , which *T*-2 is still in the experimental phase , has n't been approved *-1 yet by the Food and Drug
    Admistration , and its long - term effects are unknown .

Tree:
-----
    (TOP (S (S (NP-SBJ-1 (NP (DT The)
                             (NN drug))
                         (, ,)
                         (SBAR (WHNP-2 (WDT which))
                               (S (NP-SBJ (-NONE- *T*-2))
                                  (VP (VBZ is)
                                      (ADVP-TMP (RB still))
                                      (PP-LOC-PRD (IN in)
                                                  (NP (DT the)
                                                      (JJ experimental)
                                                      (NN phase))))))
                         (, ,))
               (VP (VBZ has)
                   (RB n't)
                   (VP (VBN been)
                       (VP (VBN approved)
                           (NP (-NONE- *-1))
                           (ADVP-TMP (RB yet))
                           (PP (IN by)
                               (NP-LGS (DT the)
                                       (NML (NNP Food)
                                            (CC and)
                                            (NNP Drug))
                                       (NNP Admistration)))))))
            (, ,)
            (CC and)
            (S (NP-SBJ (PRP$ its)
                       (NML (JJ long)
                            (HYPH -)
                            (NN term))
                       (NNS effects))
               (VP (VBP are)
                   (ADJP-PRD (JJ unknown))))
            (. .)))

Leaves:
-------
    0   The
    1   drug
    2   ,
    3   which
    4   *T*-2
    5   is
           prop:  be.01
            v          * -> 5:0,  is
            ARG1       * -> 4:0,  *T*-2 -> 3:1, which
            ARGM-TMP   * -> 6:1,  still
            ARG2       * -> 7:1,  in the experimental phase
            LINK-SLC   * -> 0:1,  The drug
                       * -> 4:0,  *T*-2 -> 3:1, which
    6   still
    7   in
    8   the
    9   experimental
    10  phase
    11  ,
    12  has
    13  n't
    14  been
    15  approved
           prop:  approve.01
            v          * -> 15:0, approved
            ARGM-NEG   * -> 13:0, n't
            ARG1       * -> 16:0, *-1 -> 0:2, The drug , which *T*-2 is still in the experimental phase ,
            ARGM-TMP   * -> 17:1, yet
            ARG0       * -> 18:1, by the Food and Drug Admistration
    16  *-1
    17  yet
    18  by
    19  the
           name:  ORG                19-23  the Food and Drug Admistration
    20  Food
    21  and
    22  Drug
    23  Admistration
    24  ,
    25  and
    26  its
    27  long
    28  -
    29  term
    30  effects
    31  are
           prop:  be.01
            v          * -> 31:0, are
            ARG1       * -> 26:1, its long - term effects
            ARG2       * -> 32:1, unknown
    32  unknown
    33  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    But researchers say the drug, called FK-506, could revolutionize the transplantation field by reducing harmful side
    effects and by lowering rejection rates.

Treebanked sentence:
--------------------
    But researchers say 0 the drug , called *PRO* *PRO*-507 FK - 506 , could revolutionize the transplantation field by
    *PRO* reducing harmful side effects and by *PRO* lowering rejection rates .

Tree:
-----
    (TOP (S (CC But)
            (NP-SBJ (NNS researchers))
            (VP (VBP say)
                (SBAR (-NONE- 0)
                      (S (NP-SBJ (NP (DT the)
                                     (NN drug))
                                 (, ,)
                                 (VP (VBN called)
                                     (NP-507 (-NONE- *PRO*))
                                     (S-CLR (NP-SBJ (-NONE- *PRO*-507))
                                            (NP-PRD (NNP FK)
                                                    (HYPH -)
                                                    (CD 506))))
                                 (, ,))
                         (VP (MD could)
                             (VP (VB revolutionize)
                                 (NP (DT the)
                                     (NN transplantation)
                                     (NN field))
                                 (PP-MNR (PP (IN by)
                                             (S-NOM (NP-SBJ (-NONE- *PRO*))
                                                    (VP (VBG reducing)
                                                        (NP (JJ harmful)
                                                            (JJ side)
                                                            (NNS effects)))))
                                         (CC and)
                                         (PP (IN by)
                                             (S-NOM (NP-SBJ (-NONE- *PRO*))
                                                    (VP (VBG lowering)
                                                        (NP (NN rejection)
                                                            (NNS rates)))))))))))
            (. .)))

Leaves:
-------
    0   But
    1   researchers
    2   say
           prop:  say.01
            v          * -> 2:0,  say
            ARGM-DIS   * -> 0:0,  But
            ARG0       * -> 1:1,  researchers
            ARG1       * -> 3:1,  0 the drug , called *PRO* *PRO*-507 FK - 506 , could revolutionize the transplantation
                                  field by *PRO* reducing harmful side effects and by *PRO* lowering rejection rates
    3   0
    4   the
    5   drug
    6   ,
    7   called
           prop:  call.01
            v          * -> 7:0,  called
            ARG1       * -> 8:0,  *PRO*
            ARG2       * -> 9:2,  *PRO*-507 FK - 506
            LINK-PCR   * -> 4:1,  the drug
                       * -> 8:0,  *PRO*
    8   *PRO*
    9   *PRO*-507
    10  FK
    11  -
    12  506
    13  ,
    14  could
    15  revolutionize
           prop:  revolutionize.01
            v          * -> 15:0, revolutionize
            ARG0       * -> 4:2,  the drug , called *PRO* *PRO*-507 FK - 506 ,
            ARGM-MOD   * -> 14:0, could
            ARG1       * -> 16:1, the transplantation field
            ARGM-MNR   * -> 19:2, by *PRO* reducing harmful side effects and by *PRO* lowering rejection rates
    16  the
    17  transplantation
    18  field
    19  by
    20  *PRO*
    21  reducing
           prop:  reduce.01
            v          * -> 21:0, reducing
            ARG0       * -> 20:0, *PRO*
            ARG1       * -> 22:1, harmful side effects
            LINK-PCR   * -> 4:2,  the drug , called *PRO* *PRO*-507 FK - 506 ,
                       * -> 20:0, *PRO*
    22  harmful
    23  side
    24  effects
    25  and
    26  by
    27  *PRO*
    28  lowering
           sense: lower-v.2
           prop:  lower.01
            v          * -> 28:0, lowering
            ARG0       * -> 27:0, *PRO*
            ARG1       * -> 29:1, rejection rates
            LINK-PCR   * -> 4:2,  the drug , called *PRO* *PRO*-507 FK - 506 ,
                       * -> 27:0, *PRO*
    29  rejection
    30  rates
    31  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Rejection has been the major obstacle in the approximately 30,000 organ transplants performed world-wide each year.

Treebanked sentence:
--------------------
    Rejection has been the major obstacle in the approximately 30,000 organ transplants performed * world - wide each year .

Tree:
-----
    (TOP (S (NP-SBJ (NN Rejection))
            (VP (VBZ has)
                (VP (VBN been)
                    (NP-PRD (DT the)
                            (JJ major)
                            (NN obstacle))
                    (PP-LOC (IN in)
                            (NP (NP (DT the)
                                    (QP (RB approximately)
                                        (CD 30,000))
                                    (NN organ)
                                    (NNS transplants))
                                (VP (VBN performed)
                                    (NP (-NONE- *))
                                    (ADVP-LOC (NN world)
                                              (HYPH -)
                                              (RB wide))
                                    (NP-TMP (DT each)
                                            (NN year)))))))
            (. .)))

Leaves:
-------
    0   Rejection
    1   has
    2   been
           prop:  be.01
            v          * -> 2:0,  been
            ARG1       * -> 0:1,  Rejection
            ARG2       * -> 3:1,  the major obstacle
            ARGM-LOC   * -> 6:1,  in the approximately 30,000 organ transplants performed * world - wide each year
    3   the
    4   major
    5   obstacle
    6   in
    7   the
    8   approximately
           name:  CARDINAL           8-9    approximately 30,000
    9   30,000
    10  organ
    11  transplants
    12  performed
           prop:  perform.01
            v          * -> 12:0, performed
            ARG1       * -> 13:0, *
            ARGM-LOC   * -> 14:1, world - wide
            ARGM-TMP   * -> 17:1, each year
            LINK-PCR   * -> 7:1,  the approximately 30,000 organ transplants
                       * -> 13:0, *
    13  *
    14  world
    15  -
    16  wide
    17  each
           name:  DATE               17-18  each year
    18  year
    19  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Researchers began using the drug in February on patients who had received kidney, liver, heart and pancreas transplants.

Treebanked sentence:
--------------------
    Researchers began *-2 using the drug *ICH*-3 in February on patients who *T*-1 had received kidney , liver , heart and
    pancreas transplants .

Tree:
-----
    (TOP (S (NP-SBJ-2 (NNS Researchers))
            (VP (VBD began)
                (S (NP-SBJ (-NONE- *-2))
                   (VP (VBG using)
                       (NP (DT the)
                           (NN drug))
                       (PP-CLR (-NONE- *ICH*-3))))
                (PP-TMP (IN in)
                        (NP (NNP February)))
                (PP-CLR-3 (IN on)
                          (NP (NP (NNS patients))
                              (SBAR (WHNP-1 (WP who))
                                    (S (NP-SBJ (-NONE- *T*-1))
                                       (VP (VBD had)
                                           (VP (VBN received)
                                               (NP (NML (NN kidney)
                                                        (, ,)
                                                        (NN liver)
                                                        (, ,)
                                                        (NN heart)
                                                        (CC and)
                                                        (NN pancreas))
                                                   (NNS transplants)))))))))
            (. .)))

Leaves:
-------
    0   Researchers
    1   began
           prop:  begin.01
            v          * -> 1:0,  began
            ARG0       * -> 0:1,  Researchers
            ARG1       * -> 2:2,  *-2 using the drug *ICH*-3
            ARGM-TMP   * -> 7:1,  in February
            ARGM-ADV   * -> 9:1,  on patients who *T*-1 had received kidney , liver , heart and pancreas transplants
    2   *-2
    3   using
           prop:  use.01
            v          * -> 3:0,  using
            ARG0       * -> 2:0,  *-2 -> 0:1, Researchers
            ARG1       * -> 4:1,  the drug
    4   the
    5   drug
    6   *ICH*-3
    7   in
    8   February
           name:  DATE               8-8    February
    9   on
    10  patients
    11  who
    12  *T*-1
    13  had
    14  received
           prop:  receive.01
            v          * -> 14:0, received
            ARG0       * -> 12:0, *T*-1 -> 11:1, who
            ARG1       * -> 15:2, kidney , liver , heart and pancreas transplants
            LINK-SLC   * -> 10:1, patients
                       * -> 12:0, *T*-1 -> 11:1, who
    15  kidney
    16  ,
    17  liver
    18  ,
    19  heart
    20  and
    21  pancreas
    22  transplants
    23  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Only two of 111 transplants have been rejected.

Treebanked sentence:
--------------------
    Only two of 111 transplants have been rejected *-1 .

Tree:
-----
    (TOP (S (NP-SBJ-1 (QP (RB Only)
                          (CD two)
                          (IN of)
                          (CD 111))
                      (NNS transplants))
            (VP (VBP have)
                (VP (VBN been)
                    (VP (VBN rejected)
                        (NP (-NONE- *-1)))))
            (. .)))

Leaves:
-------
    0   Only
        !  name:  CARDINAL           0-1    Only two
    1   two
    2   of
    3   111
           name:  CARDINAL           3-3    111
    4   transplants
    5   have
    6   been
    7   rejected
           prop:  reject.01
            v          * -> 7:0,  rejected
            ARG1       * -> 8:0,  *-1 -> 0:2, Only two of 111 transplants
            LINK-PCR   * -> 8:0,  *-1 -> 0:2, Only two of 111 transplants
                       * -> 8:0,  *-1 -> 0:2, Only two of 111 transplants
    8   *-1
    9   .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    The drug, discovered in 1984, is metabolized from soil fungus found in Japan.

Treebanked sentence:
--------------------
    The drug , discovered * in 1984 , is metabolized *-1 from soil fungus found * in Japan .

Tree:
-----
    (TOP (S (NP-SBJ-1 (NP (DT The)
                          (NN drug))
                      (, ,)
                      (VP (VBN discovered)
                          (NP (-NONE- *))
                          (PP-TMP (IN in)
                                  (NP (CD 1984))))
                      (, ,))
            (VP (VBZ is)
                (VP (VBN metabolized)
                    (NP (-NONE- *-1))
                    (PP-CLR (IN from)
                            (NP (NP (NN soil)
                                    (NN fungus))
                                (VP (VBN found)
                                    (NP (-NONE- *))
                                    (PP-TMP (IN in)
                                            (NP (NNP Japan))))))))
            (. .)))

Leaves:
-------
    0   The
    1   drug
    2   ,
    3   discovered
           prop:  discover.01
            v          * -> 3:0,  discovered
            ARG1       * -> 4:0,  *
            ARGM-TMP   * -> 5:1,  in 1984
            LINK-PCR   * -> 0:1,  The drug
                       * -> 4:0,  *
    4   *
    5   in
    6   1984
           name:  DATE               6-6    1984
    7   ,
    8   is
    9   metabolized
           prop:  metabolize.01
            v          * -> 9:0,  metabolized
            ARG1       * -> 10:0, *-1 -> 0:2, The drug , discovered * in 1984 ,
            ARG2       * -> 11:1, from soil fungus found * in Japan
    10  *-1
    11  from
    12  soil
    13  fungus
    14  found
           prop:  find.01
            v          * -> 14:0, found
            ARG1       * -> 15:0, *
            ARGM-LOC   * -> 16:1, in Japan
            LINK-PCR   * -> 12:1, soil fungus
                       * -> 15:0, *
    15  *
    16  in
    17  Japan
           name:  GPE                17-17  Japan
    18  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    The Pittsburgh patients are the first humans to be given the drug, which is made by Fujisawa Pharmaceutical Co.

Treebanked sentence:
--------------------
    The Pittsburgh patients are the first humans 0 *T*-4 to be given *-1 the drug , which *T*-3 is made *-2 by Fujisawa
    Pharmaceutical Co .

Tree:
-----
    (TOP (S (NP-SBJ (DT The)
                    (NNP Pittsburgh)
                    (NNS patients))
            (VP (VBP are)
                (NP-PRD (NP (DT the)
                            (JJ first)
                            (NNS humans))
                        (SBAR (WHNP-4 (-NONE- 0))
                              (S (NP-SBJ-1 (-NONE- *T*-4))
                                 (VP (TO to)
                                     (VP (VB be)
                                         (VP (VBN given)
                                             (NP (-NONE- *-1))
                                             (NP (NP (DT the)
                                                     (NN drug))
                                                 (, ,)
                                                 (SBAR (WHNP-3 (WDT which))
                                                       (S (NP-SBJ-2 (-NONE- *T*-3))
                                                          (VP (VBZ is)
                                                              (VP (VBN made)
                                                                  (NP (-NONE- *-2))
                                                                  (PP (IN by)
                                                                      (NP-LGS (NNP Fujisawa)
                                                                              (NNP Pharmaceutical)
                                                                              (NNP Co)))))))))))))))
            (. .)))

Leaves:
-------
    0   The
    1   Pittsburgh
           name:  GPE                1-1    Pittsburgh
    2   patients
    3   are
           prop:  be.01
            v          * -> 3:0,  are
            ARG1       * -> 0:1,  The Pittsburgh patients
            ARG2       * -> 4:2,  the first humans 0 *T*-4 to be given *-1 the drug , which *T*-3 is made *-2 by
                                  Fujisawa Pharmaceutical Co
    4   the
    5   first
    6   humans
    7   0
    8   *T*-4
    9   to
    10  be
    11  given
           prop:  give.01
            v          * -> 11:0, given
            ARG2       * -> 12:0, *-1 -> 8:0, *T*-4 -> 7:0, 0
            ARG1       * -> 13:2, the drug , which *T*-3 is made *-2 by Fujisawa Pharmaceutical Co
            LINK-SLC   * -> 4:1,  the first humans
                       * -> 12:0, *-1 -> 8:0, *T*-4 -> 7:0, 0
                       * -> 12:0, *-1 -> 8:0, *T*-4 -> 7:0, 0
                       * -> 12:0, *-1 -> 8:0, *T*-4 -> 7:0, 0
            LINK-PCR   * -> 12:0, *-1 -> 8:0, *T*-4 -> 7:0, 0
                       * -> 12:0, *-1 -> 8:0, *T*-4 -> 7:0, 0
                       * -> 12:0, *-1 -> 8:0, *T*-4 -> 7:0, 0
    12  *-1
    13  the
    14  drug
    15  ,
    16  which
    17  *T*-3
    18  is
    19  made
           prop:  make.01
            v          * -> 19:0, made
            ARG1       * -> 20:0, *-2 -> 17:0, *T*-3 -> 16:1, which
            ARG0       * -> 21:1, by Fujisawa Pharmaceutical Co
            LINK-SLC   * -> 13:1, the drug
                       * -> 20:0, *-2 -> 17:0, *T*-3 -> 16:1, which
                       * -> 20:0, *-2 -> 17:0, *T*-3 -> 16:1, which
                       * -> 20:0, *-2 -> 17:0, *T*-3 -> 16:1, which
            LINK-PCR   * -> 20:0, *-2 -> 17:0, *T*-3 -> 16:1, which
                       * -> 20:0, *-2 -> 17:0, *T*-3 -> 16:1, which
                       * -> 20:0, *-2 -> 17:0, *T*-3 -> 16:1, which
    20  *-2
    21  by
    22  Fujisawa
           name:  ORG                22-24  Fujisawa Pharmaceutical Co
    23  Pharmaceutical
    24  Co
    25  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    `` We 're shocked by it, because it's worked so fast, '' said Dr. Thomas E. Starzl, director of the University of
    Pittsburgh Transplantation Program, at a news conference here yesterday.

Treebanked sentence:
--------------------
    `` We 're shocked by it , because it 's worked so fast , '' said *T*-1 Dr. Thomas E. Starzl , director of the University
    of Pittsburgh Transplantation Program , at a news conference here yesterday .

Tree:
-----
    (TOP (SINV (`` ``)
               (S-TPC-1 (NP-SBJ (PRP We))
                        (VP (VBP 're)
                            (VP (JJ shocked)
                                (PP (IN by)
                                    (NP (PRP it)))))
                        (, ,)
                        (SBAR (IN because)
                              (S (NP-SBJ (PRP it))
                                 (VP (VBZ 's)
                                     (VP (VBN worked)
                                         (ADVP (RB so)
                                               (RB fast)))))))
               (, ,)
               ('' '')
               (VP (VBD said)
                   (S (-NONE- *T*-1)))
               (NP-SBJ (NP (NNP Dr.)
                           (NNP Thomas)
                           (NNP E.)
                           (NNP Starzl))
                       (, ,)
                       (NP (NP (NN director))
                           (PP (IN of)
                               (NP (DT the)
                                   (NML (NML (NNP University))
                                        (PP (IN of)
                                            (NP (NNP Pittsburgh))))
                                   (NNP Transplantation)
                                   (NNP Program))))
                       (, ,))
               (PP-LOC (IN at)
                       (NP (DT a)
                           (NN news)
                           (NN conference)))
               (ADVP-LOC (RB here))
               (NP-TMP (NN yesterday))
               (. .)))

Leaves:
-------
    0   ``
    1   We
    2   're
           prop:  be.03
            v          * -> 2:0,  're
    3   shocked
    4   by
    5   it
    6   ,
    7   because
    8   it
    9   's
           prop:  have.01
            v          * -> 9:0,  's
    10  worked
           prop:  work.01
            v          * -> 10:0, worked
            ARG0       * -> 8:1,  it
            ARGM-MNR   * -> 11:1, so fast
    11  so
    12  fast
    13  ,
    14  ''
    15  said
           prop:  say.01
            v          * -> 15:0, said
            ARG1       * -> 16:0, *T*-1 -> 1:2, We 're shocked by it , because it 's worked so fast
            ARG0       * -> 17:2, Dr. Thomas E. Starzl , director of the University of Pittsburgh Transplantation
                                  Program ,
            ARGM-LOC   * -> 31:1, at a news conference
            ARGM-LOC   * -> 35:1, here
            ARGM-TMP   * -> 36:1, yesterday
    16  *T*-1
    17  Dr.
    18  Thomas
        !  name:  PERSON             18-20  Thomas E. Starzl
    19  E.
    20  Starzl
    21  ,
    22  director
    23  of
    24  the
           name:  ORG                24-29  the University of Pittsburgh Transplantation Program
    25  University
    26  of
    27  Pittsburgh
    28  Transplantation
    29  Program
    30  ,
    31  at
    32  a
    33  news
    34  conference
    35  here
    36  yesterday
           name:  DATE               36-36  yesterday
    37  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    `` We consider it a life-saving drug, like one for AIDS, '' said Dr. John Fung, an immunologist at the University of
    Pittsburgh.

Treebanked sentence:
--------------------
    `` We consider it a life - saving drug , like one for AIDS , '' said *T*-1 Dr. John Fung , an immunologist at the
    University of Pittsburgh .

Tree:
-----
    (TOP (SINV (`` ``)
               (S-TPC-1 (NP-SBJ (PRP We))
                        (VP (VBP consider)
                            (S (NP-SBJ (PRP it))
                               (NP-PRD (NP (DT a)
                                           (ADJP (NN life)
                                                 (HYPH -)
                                                 (VBG saving))
                                           (NN drug))
                                       (, ,)
                                       (PP (IN like)
                                           (NP (NP (CD one))
                                               (PP (IN for)
                                                   (NP (NNP AIDS)))))))))
               (, ,)
               ('' '')
               (VP (VBD said)
                   (S (-NONE- *T*-1)))
               (NP-SBJ (NP (NNP Dr.)
                           (NNP John)
                           (NNP Fung))
                       (, ,)
                       (NP (NP (DT an)
                               (NN immunologist))
                           (PP-LOC (IN at)
                                   (NP (NP (DT the)
                                           (NNP University))
                                       (PP (IN of)
                                           (NP (NNP Pittsburgh)))))))
               (. .)))

Leaves:
-------
    0   ``
    1   We
    2   consider
           prop:  consider.01
            v          * -> 2:0,  consider
            ARG0       * -> 1:1,  We
            ARG1       * -> 3:2,  it a life - saving drug , like one for AIDS
    3   it
    4   a
    5   life
    6   -
    7   saving
    8   drug
    9   ,
    10  like
    11  one
    12  for
    13  AIDS
    14  ,
    15  ''
    16  said
           prop:  say.01
            v          * -> 16:0, said
            ARG1       * -> 17:0, *T*-1 -> 1:2, We consider it a life - saving drug , like one for AIDS
            ARG0       * -> 18:2, Dr. John Fung , an immunologist at the University of Pittsburgh
    17  *T*-1
    18  Dr.
    19  John
        !  name:  PERSON             19-20  John Fung
    20  Fung
    21  ,
    22  an
    23  immunologist
    24  at
    25  the
           name:  ORG                25-28  the University of Pittsburgh
    26  University
    27  of
    28  Pittsburgh
    29  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Researchers say they believe FK-506 is 100 times more effective than the traditional anti-rejection drug, cyclosporine,
    made by Swiss pharmaceutical giant Sandoz Ltd.

Treebanked sentence:
--------------------
    Researchers say 0 they believe 0 FK - 506 is 100 times more effective than the traditional anti-rejection drug ,
    cyclosporine , made * by Swiss pharmaceutical giant Sandoz Ltd .

Tree:
-----
    (TOP (S (NP-SBJ (NNS Researchers))
            (VP (VBP say)
                (SBAR (-NONE- 0)
                      (S (NP-SBJ (PRP they))
                         (VP (VBP believe)
                             (SBAR (-NONE- 0)
                                   (S (NP-SBJ (NNP FK)
                                              (HYPH -)
                                              (CD 506))
                                      (VP (VBZ is)
                                          (ADJP-PRD (ADJP (QP (CD 100)
                                                              (NNS times))
                                                          (RBR more)
                                                          (JJ effective))
                                                    (PP (IN than)
                                                        (NP (NP (NP (DT the)
                                                                    (JJ traditional)
                                                                    (JJ anti-rejection)
                                                                    (NN drug))
                                                                (, ,)
                                                                (NP (NN cyclosporine)))
                                                            (, ,)
                                                            (VP (VBN made)
                                                                (NP (-NONE- *))
                                                                (PP (IN by)
                                                                    (NP-LGS (NML (JJ Swiss)
                                                                                 (NN pharmaceutical)
                                                                                 (NN giant))
                                                                            (NNP Sandoz)
                                                                            (NNP Ltd))))))))))))))
            (. .)))

Leaves:
-------
    0   Researchers
    1   say
           prop:  say.01
            v          * -> 1:0,  say
            ARG0       * -> 0:1,  Researchers
            ARG1       * -> 2:1,  0 they believe 0 FK - 506 is 100 times more effective than the traditional
                                  anti-rejection drug , cyclosporine , made * by Swiss pharmaceutical giant Sandoz Ltd
    2   0
    3   they
    4   believe
           prop:  believe.01
            v          * -> 4:0,  believe
            ARG0       * -> 3:1,  they
            ARG1       * -> 5:1,  0 FK - 506 is 100 times more effective than the traditional anti-rejection drug ,
                                  cyclosporine , made * by Swiss pharmaceutical giant Sandoz Ltd
    5   0
    6   FK
    7   -
    8   506
    9   is
           prop:  be.01
            v          * -> 9:0,  is
            ARG1       * -> 6:1,  FK - 506
            ARG2       * -> 10:3, 100 times more effective than the traditional anti-rejection drug , cyclosporine ,
                                  made * by Swiss pharmaceutical giant Sandoz Ltd
    10  100
           name:  CARDINAL           10-10  100
    11  times
    12  more
    13  effective
    14  than
    15  the
    16  traditional
    17  anti-rejection
    18  drug
    19  ,
    20  cyclosporine
    21  ,
    22  made
           prop:  make.01
            v          * -> 22:0, made
            ARG0       * -> 24:1, by Swiss pharmaceutical giant Sandoz Ltd
            ARG1       * -> 15:1, the traditional anti-rejection drug
                         -> 20:1, cyclosporine
                       * -> 23:0, *
    23  *
    24  by
    25  Swiss
           name:  NORP               25-25  Swiss
    26  pharmaceutical
    27  giant
    28  Sandoz
        !  name:  ORG                28-29  Sandoz Ltd
    29  Ltd
    30  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    They are also encouraged by the relatively mild side effects of FK-506, compared with cyclosporine, which can cause
    renal failure, morbidity, nausea and other problems.

Treebanked sentence:
--------------------
    They are also encouraged *-1 by the relatively mild side effects of FK - 506 , compared with cyclosporine , which
    *T*-507 can cause renal failure , morbidity , nausea and other problems .

Tree:
-----
    (TOP (S (NP-SBJ-1 (PRP They))
            (VP (VBP are)
                (ADVP (RB also))
                (VP (VBN encouraged)
                    (NP (-NONE- *-1))
                    (PP (IN by)
                        (NP-LGS (NP (DT the)
                                    (ADJP (RB relatively)
                                          (JJ mild))
                                    (JJ side)
                                    (NNS effects))
                                (PP (IN of)
                                    (NP (NNP FK)
                                        (HYPH -)
                                        (CD 506)))
                                (, ,)
                                (PP (VBN compared)
                                    (PP (IN with)
                                        (NP (NP (NN cyclosporine))
                                            (, ,)
                                            (SBAR (WHNP-507 (WDT which))
                                                  (S (NP-SBJ (-NONE- *T*-507))
                                                     (VP (MD can)
                                                         (VP (VB cause)
                                                             (NP (NP (JJ renal)
                                                                     (NN failure))
                                                                 (, ,)
                                                                 (NP (NN morbidity))
                                                                 (, ,)
                                                                 (NP (NN nausea))
                                                                 (CC and)
                                                                 (NP (JJ other)
                                                                     (NNS problems))))))))))))))
            (. .)))

Leaves:
-------
    0   They
    1   are
    2   also
    3   encouraged
           prop:  encourage.02
            v          * -> 3:0,  encouraged
            ARGM-ADV   * -> 2:1,  also
            ARG1       * -> 4:0,  *-1 -> 0:1, They
            ARG0       * -> 5:1,  by the relatively mild side effects of FK - 506 , compared with cyclosporine , which
                                  *T*-507 can cause renal failure , morbidity , nausea and other problems
            LINK-PCR   * -> 4:0,  *-1 -> 0:1, They
                       * -> 4:0,  *-1 -> 0:1, They
    4   *-1
    5   by
    6   the
    7   relatively
    8   mild
    9   side
    10  effects
    11  of
    12  FK
    13  -
    14  506
    15  ,
    16  compared
    17  with
    18  cyclosporine
    19  ,
    20  which
    21  *T*-507
    22  can
    23  cause
           sense: cause-v.1
           prop:  cause.01
            v          * -> 23:0, cause
            ARG0       * -> 21:0, *T*-507 -> 20:1, which
            ARGM-MOD   * -> 22:0, can
            ARG1       * -> 24:2, renal failure , morbidity , nausea and other problems
            LINK-SLC   * -> 18:1, cyclosporine
                       * -> 21:0, *T*-507 -> 20:1, which
    24  renal
    25  failure
    26  ,
    27  morbidity
    28  ,
    29  nausea
    30  and
    31  other
    32  problems
    33  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    `` The side effects-LCB-of cyclosporine-RCB-have made the penalty for its success rather high, '' Dr. Starzl said.

Treebanked sentence:
--------------------
    `` The side effects -LCB- of cyclosporine -RCB- have made the penalty for its success rather high , '' Dr. Starzl said
    *T*-1 .

Tree:
-----
    (TOP (S (`` ``)
            (S-1 (NP-SBJ (NP (DT The)
                             (JJ side)
                             (NNS effects))
                         (-LRB- -LCB-)
                         (PP (IN of)
                             (NP (NN cyclosporine)))
                         (-RRB- -RCB-))
                 (VP (VBP have)
                     (VP (VBN made)
                         (S (NP-SBJ (NP (DT the)
                                        (NN penalty))
                                    (PP (IN for)
                                        (NP (PRP$ its)
                                            (NN success))))
                            (ADJP-PRD (RB rather)
                                      (JJ high))))))
            (, ,)
            ('' '')
            (NP-SBJ (NNP Dr.)
                    (NNP Starzl))
            (VP (VBD said)
                (S (-NONE- *T*-1)))
            (. .)))

Leaves:
-------
    0   ``
    1   The
    2   side
    3   effects
    4   -LCB-
    5   of
    6   cyclosporine
    7   -RCB-
    8   have
    9   made
           prop:  make.02
            v          * -> 9:0,  made
            ARG0       * -> 1:2,  The side effects -LCB- of cyclosporine -RCB-
            ARG1       * -> 10:3, the penalty for its success rather high
    10  the
    11  penalty
    12  for
    13  its
    14  success
    15  rather
    16  high
    17  ,
    18  ''
    19  Dr.
    20  Starzl
           name:  PERSON             20-20  Starzl
    21  said
           prop:  say.01
            v          * -> 21:0, said
            ARG0       * -> 19:1, Dr. Starzl
            ARG1       * -> 22:0, *T*-1 -> 1:3, The side effects -LCB- of cyclosporine -RCB- have made the penalty for
                                                its success rather high
    22  *T*-1
    23  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Dr. Fung said that FK-506 would not be available in the market for at least a year, and that the FDA approval process
    usually takes three years to five years.

Treebanked sentence:
--------------------
    Dr. Fung said that FK - 506 would not be available in the market for at least a year , and that the FDA approval process
    usually takes three years to five years .

Tree:
-----
    (TOP (S (NP-SBJ (NNP Dr.)
                    (NNP Fung))
            (VP (VBD said)
                (SBAR (SBAR (IN that)
                            (S (NP-SBJ (NNP FK)
                                       (HYPH -)
                                       (CD 506))
                               (VP (MD would)
                                   (RB not)
                                   (VP (VB be)
                                       (ADJP-PRD (JJ available))
                                       (PP-LOC (IN in)
                                               (NP (DT the)
                                                   (NN market)))
                                       (PP-TMP (IN for)
                                               (NP (QP (ADVP (RB at)
                                                             (RBS least))
                                                       (DT a))
                                                   (NN year)))))))
                      (, ,)
                      (CC and)
                      (SBAR (IN that)
                            (S (NP-SBJ (DT the)
                                       (NNP FDA)
                                       (NN approval)
                                       (NN process))
                               (ADVP-TMP (RB usually))
                               (VP (VBZ takes)
                                   (NP (NP (CD three)
                                           (NNS years))
                                       (TO to)
                                       (NP (CD five)
                                           (NNS years))))))))
            (. .)))

Leaves:
-------
    0   Dr.
    1   Fung
           name:  PERSON             1-1    Fung
    2   said
           prop:  say.01
            v          * -> 2:0,  said
            ARG0       * -> 0:1,  Dr. Fung
            ARG1       * -> 3:2,  that FK - 506 would not be available in the market for at least a year , and that the
                                  FDA approval process usually takes three years to five years
    3   that
    4   FK
    5   -
    6   506
    7   would
    8   not
    9   be
           prop:  be.01
            v          * -> 9:0,  be
            ARG1       * -> 4:1,  FK - 506
            ARGM-MOD   * -> 7:0,  would
            ARGM-NEG   * -> 8:0,  not
            ARG2       * -> 10:1, available
            ARGM-LOC   * -> 11:1, in the market
            ARGM-TMP   * -> 14:1, for at least a year
    10  available
    11  in
    12  the
    13  market
    14  for
    15  at
           name:  DATE               15-18  at least a year
    16  least
    17  a
    18  year
    19  ,
    20  and
    21  that
    22  the
    23  FDA
           name:  ORG                23-23  FDA
    24  approval
    25  process
    26  usually
    27  takes
           prop:  take.02
            v          * -> 27:0, takes
            ARG0       * -> 22:1, the FDA approval process
            ARGM-TMP   * -> 26:1, usually
            ARG1       * -> 28:2, three years to five years
    28  three
           name:  DATE               28-32  three years to five years
    29  years
    30  to
    31  five
    32  years
    33  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    There are no firm plans to expand the experimental program beyond the University of Pittsburgh, whose hospital performs
    the most transplants in the world.

Treebanked sentence:
--------------------
    There are no firm plans *PRO* to expand the experimental program beyond the University of Pittsburgh , whose hospital
    *T*-1 performs the most transplants in the world .

Tree:
-----
    (TOP (S (NP-SBJ (EX There))
            (VP (VBP are)
                (NP-PRD (DT no)
                        (JJ firm)
                        (NNS plans)
                        (S (NP-SBJ (-NONE- *PRO*))
                           (VP (TO to)
                               (VP (VB expand)
                                   (NP (DT the)
                                       (JJ experimental)
                                       (NN program))
                                   (PP-DIR-CLR (IN beyond)
                                               (NP (NP (NP (DT the)
                                                           (NNP University))
                                                       (PP (IN of)
                                                           (NP (NNP Pittsburgh))))
                                                   (, ,)
                                                   (SBAR (WHNP-1 (WP$ whose)
                                                                 (NN hospital))
                                                         (S (NP-SBJ (-NONE- *T*-1))
                                                            (VP (VBZ performs)
                                                                (NP (NP (DT the)
                                                                        (JJS most)
                                                                        (NNS transplants))
                                                                    (PP-LOC (IN in)
                                                                            (NP (DT the)
                                                                                (NN world))))))))))))))
            (. .)))

Leaves:
-------
    0   There
    1   are
           prop:  be.02
            v          * -> 1:0,  are
            ARG1       * -> 2:1,  no firm plans *PRO* to expand the experimental program beyond the University of
                                  Pittsburgh , whose hospital *T*-1 performs the most transplants in the world
    2   no
    3   firm
    4   plans
    5   *PRO*
    6   to
    7   expand
           prop:  expand.01
            v          * -> 7:0,  expand
            ARG0       * -> 5:0,  *PRO*
            ARG1       * -> 8:1,  the experimental program
            ARG2       * -> 11:1, beyond the University of Pittsburgh , whose hospital *T*-1 performs the most
                                  transplants in the world
    8   the
    9   experimental
    10  program
    11  beyond
    12  the
           name:  ORG                12-15  the University of Pittsburgh
    13  University
    14  of
    15  Pittsburgh
    16  ,
    17  whose
    18  hospital
    19  *T*-1
    20  performs
           prop:  perform.01
            v          * -> 20:0, performs
            ARG0       * -> 19:0, *T*-1 -> 17:1, whose hospital
            ARG1       * -> 21:2, the most transplants in the world
            LINK-SLC   * -> 12:2, the University of Pittsburgh
                       * -> 19:0, *T*-1 -> 17:1, whose hospital
    21  the
    22  most
    23  transplants
    24  in
    25  the
    26  world
    27  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Researchers could n't estimate the cost of the drug when it reaches the market, but they said FK-506 will enable
    patients to cut hospital stays by 50 % and reduce the number of blood tests used to monitor the dosage of cyclosporine
    and other drugs among transplant recipients.

Treebanked sentence:
--------------------
    Researchers could n't estimate the cost of the drug when it reaches the market *T*-1 , but they said 0 FK - 506 will
    enable patients *PRO*-507 to cut hospital stays by 50 % and reduce the number of blood tests used * *PRO* to monitor the
    dosage of cyclosporine and other drugs among transplant recipients .

Tree:
-----
    (TOP (S (S (NP-SBJ (NNS Researchers))
               (VP (MD could)
                   (RB n't)
                   (VP (VB estimate)
                       (NP (NP (NP (DT the)
                                   (NN cost))
                               (PP (IN of)
                                   (NP (DT the)
                                       (NN drug))))
                           (SBAR (WHADVP-1 (WRB when))
                                 (S (NP-SBJ (PRP it))
                                    (VP (VBZ reaches)
                                        (NP (DT the)
                                            (NN market))
                                        (ADVP-TMP (-NONE- *T*-1)))))))))
            (, ,)
            (CC but)
            (S (NP-SBJ (PRP they))
               (VP (VBD said)
                   (SBAR (-NONE- 0)
                         (S (NP-SBJ (NNP FK)
                                    (HYPH -)
                                    (CD 506))
                            (VP (MD will)
                                (VP (VP (VB enable)
                                        (NP-507 (NNS patients))
                                        (S (NP-SBJ (-NONE- *PRO*-507))
                                           (VP (TO to)
                                               (VP (VB cut)
                                                   (NP (NN hospital)
                                                       (NNS stays))
                                                   (PP-EXT (IN by)
                                                           (NP (CD 50)
                                                               (NN %)))))))
                                    (CC and)
                                    (VP (VB reduce)
                                        (NP (NP (DT the)
                                                (NN number))
                                            (PP (IN of)
                                                (NP (NP (NN blood)
                                                        (NNS tests))
                                                    (VP (VBN used)
                                                        (NP (-NONE- *))
                                                        (S-CLR (NP-SBJ (-NONE- *PRO*))
                                                               (VP (TO to)
                                                                   (VP (VB monitor)
                                                                       (NP (NP (DT the)
                                                                               (NN dosage))
                                                                           (PP (IN of)
                                                                               (NP (NP (JJ cyclosporine))
                                                                                   (CC and)
                                                                                   (NP (JJ other)
                                                                                       (NNS drugs))))))))
                                                        (PP-LOC (IN among)
                                                                (NP (NN transplant)
                                                                    (NNS recipients))))))))))))))
            (. .)))

Leaves:
-------
    0   Researchers
    1   could
    2   n't
    3   estimate
           sense: estimate-v.1
           prop:  estimate.01
            v          * -> 3:0,  estimate
            ARG0       * -> 0:1,  Researchers
            ARGM-MOD   * -> 1:0,  could
            ARGM-NEG   * -> 2:0,  n't
            ARG1       * -> 4:3,  the cost of the drug when it reaches the market *T*-1
    4   the
    5   cost
    6   of
    7   the
    8   drug
    9   when
    10  it
    11  reaches
           prop:  reach.01
            v          * -> 11:0, reaches
            ARG0       * -> 10:1, it
            ARG1       * -> 12:1, the market
            ARGM-TMP   * -> 14:0, *T*-1 -> 9:1, when
    12  the
    13  market
    14  *T*-1
    15  ,
    16  but
    17  they
    18  said
           prop:  say.01
            v          * -> 18:0, said
            ARG0       * -> 17:1, they
            ARG1       * -> 19:1, 0 FK - 506 will enable patients *PRO*-507 to cut hospital stays by 50 % and reduce the
                                  number of blood tests used * *PRO* to monitor the dosage of cyclosporine and other
                                  drugs among transplant recipients
    19  0
    20  FK
    21  -
    22  506
    23  will
    24  enable
           sense: enable-v.1
           prop:  enable.01
            v          * -> 24:0, enable
            ARG0       * -> 20:1, FK - 506
            ARGM-MOD   * -> 23:0, will
            ARG2       * -> 25:1, patients
            ARG1       * -> 26:2, *PRO*-507 to cut hospital stays by 50 %
    25  patients
    26  *PRO*-507
    27  to
    28  cut
           prop:  cut.02
            v          * -> 28:0, cut
            ARG0       * -> 26:0, *PRO*-507 -> 25:1, patients
            ARG1       * -> 29:1, hospital stays
            ARG2       * -> 31:1, by 50 %
            LINK-PCR   * -> 26:0, *PRO*-507 -> 25:1, patients
                       * -> 26:0, *PRO*-507 -> 25:1, patients
    29  hospital
    30  stays
    31  by
    32  50
           name:  PERCENT            32-33  50 %
    33  %
    34  and
    35  reduce
           prop:  reduce.01
            v          * -> 35:0, reduce
            ARG0       * -> 20:1, FK - 506
            ARGM-MOD   * -> 23:0, will
            ARG1       * -> 36:2, the number of blood tests used * *PRO* to monitor the dosage of cyclosporine and other
                                  drugs among transplant recipients
    36  the
    37  number
    38  of
    39  blood
    40  tests
    41  used
           prop:  use.01
            v          * -> 41:0, used
            ARG1       * -> 42:0, *
            ARG2       * -> 43:2, *PRO* to monitor the dosage of cyclosporine and other drugs
            ARGM-LOC   * -> 53:1, among transplant recipients
            LINK-PCR   * -> 39:1, blood tests
                       * -> 42:0, *
    42  *
    43  *PRO*
    44  to
    45  monitor
           sense: monitor-v.1
           prop:  monitor.01
            v          * -> 45:0, monitor
            ARG0       * -> 43:0, *PRO*
            ARG1       * -> 46:2, the dosage of cyclosporine and other drugs
    46  the
    47  dosage
    48  of
    49  cyclosporine
    50  and
    51  other
    52  drugs
    53  among
    54  transplant
    55  recipients
    56  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Dr. Starzl said the research has been largely financed by the National Institute of Health and by university funds, and
    that Fujisawa did n't give the hospital any grants.

Treebanked sentence:
--------------------
    Dr. Starzl said 0 the research has been largely financed *-1 by the National Institute of Health and by university funds
    , and that Fujisawa did n't give the hospital any grants .

Tree:
-----
    (TOP (S (NP-SBJ (NNP Dr.)
                    (NNP Starzl))
            (VP (VBD said)
                (SBAR (SBAR (-NONE- 0)
                            (S (NP-SBJ-1 (DT the)
                                         (NN research))
                               (VP (VBZ has)
                                   (VP (VBN been)
                                       (ADVP (RB largely))
                                       (VP (VBN financed)
                                           (NP (-NONE- *-1))
                                           (PP (PP (IN by)
                                                   (NP-LGS (NP (DT the)
                                                               (NNP National)
                                                               (NNP Institute))
                                                           (PP (IN of)
                                                               (NP (NNP Health)))))
                                               (CC and)
                                               (PP (IN by)
                                                   (NP-LGS (NN university)
                                                           (NNS funds)))))))))
                      (, ,)
                      (CC and)
                      (SBAR (IN that)
                            (S (NP-SBJ (NNP Fujisawa))
                               (VP (VBD did)
                                   (RB n't)
                                   (VP (VB give)
                                       (NP (DT the)
                                           (NN hospital))
                                       (NP (DT any)
                                           (NNS grants))))))))
            (. .)))

Leaves:
-------
    0   Dr.
    1   Starzl
           name:  PERSON             1-1    Starzl
    2   said
           prop:  say.01
            v          * -> 2:0,  said
            ARG0       * -> 0:1,  Dr. Starzl
            ARG1       * -> 3:2,  0 the research has been largely financed *-1 by the National Institute of Health and
                                  by university funds , and that Fujisawa did n't give the hospital any grants
    3   0
    4   the
    5   research
           sense: research-n.1
    6   has
    7   been
    8   largely
    9   financed
           sense: finance-v.1
           prop:  finance.01
            v          * -> 9:0,  financed
            ARGM-ADV   * -> 8:1,  largely
            ARG1       * -> 10:0, *-1 -> 4:1, the research
            ARG0       * -> 11:1, by the National Institute of Health
    10  *-1
    11  by
    12  the
           name:  ORG                12-16  the National Institute of Health
    13  National
    14  Institute
    15  of
    16  Health
    17  and
    18  by
    19  university
    20  funds
    21  ,
    22  and
    23  that
    24  Fujisawa
           name:  ORG                24-24  Fujisawa
    25  did
    26  n't
    27  give
           prop:  give.01
            v          * -> 27:0, give
            ARG0       * -> 24:1, Fujisawa
            ARGM-NEG   * -> 26:0, n't
            ARG2       * -> 28:1, the hospital
            ARG1       * -> 30:1, any grants
    28  the
    29  hospital
    30  any
    31  grants
    32  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    He said that the research team had no financial stake in the drug.

Treebanked sentence:
--------------------
    He said that the research team had no financial stake in the drug .

Tree:
-----
    (TOP (S (NP-SBJ (PRP He))
            (VP (VBD said)
                (SBAR (IN that)
                      (S (NP-SBJ (DT the)
                                 (NN research)
                                 (NN team))
                         (VP (VBD had)
                             (NP (NP (DT no)
                                     (JJ financial)
                                     (NN stake))
                                 (PP-LOC (IN in)
                                         (NP (DT the)
                                             (NN drug))))))))
            (. .)))

Leaves:
-------
    0   He
    1   said
           prop:  say.01
            v          * -> 1:0,  said
            ARG0       * -> 0:1,  He
            ARG1       * -> 2:1,  that the research team had no financial stake in the drug
    2   that
    3   the
    4   research
    5   team
    6   had
           prop:  have.03
            v          * -> 6:0,  had
            ARG0       * -> 3:1,  the research team
            ARG1       * -> 7:2,  no financial stake in the drug
    7   no
    8   financial
    9   stake
    10  in
    11  the
    12  drug
    13  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    `` We 've known for six months the effect of this drug, and our advice to our people has been not to buy the company's
    stock, '' Dr. Starzl said, adding that profiting from FK-506 would n't be ethical.

Treebanked sentence:
--------------------
    `` We 've known for six months the effect of this drug , and our advice to our people has been *PRO* not to buy the
    company 's stock , '' Dr. Starzl said *T*-2 , *PRO*-1 adding that *PRO* profiting from FK - 506 would n't be ethical .

Tree:
-----
    (TOP (S (`` ``)
            (S-TPC-2 (S (NP-SBJ (PRP We))
                        (VP (VBP 've)
                            (VP (VBN known)
                                (PP-TMP (IN for)
                                        (NP (CD six)
                                            (NNS months)))
                                (NP (NP (DT the)
                                        (NN effect))
                                    (PP (IN of)
                                        (NP (DT this)
                                            (NN drug)))))))
                     (, ,)
                     (CC and)
                     (S (NP-SBJ (NP (PRP$ our)
                                    (NN advice))
                                (PP (IN to)
                                    (NP (PRP$ our)
                                        (NNS people))))
                        (VP (VBZ has)
                            (VP (VBN been)
                                (S-PRD (NP-SBJ (-NONE- *PRO*))
                                       (RB not)
                                       (VP (TO to)
                                           (VP (VB buy)
                                               (NP (NP (DT the)
                                                       (NN company)
                                                       (POS 's))
                                                   (NN stock)))))))))
            (, ,)
            ('' '')
            (NP-SBJ-1 (NNP Dr.)
                      (NNP Starzl))
            (VP (VBD said)
                (S (-NONE- *T*-2))
                (, ,)
                (S-ADV (NP-SBJ (-NONE- *PRO*-1))
                       (VP (VBG adding)
                           (SBAR (IN that)
                                 (S (S-NOM-SBJ (NP-SBJ (-NONE- *PRO*))
                                               (VP (VBG profiting)
                                                   (PP-CLR (IN from)
                                                           (NP (NNP FK)
                                                               (HYPH -)
                                                               (CD 506)))))
                                    (VP (MD would)
                                        (RB n't)
                                        (VP (VB be)
                                            (ADJP-PRD (JJ ethical)))))))))
            (. .)))

Leaves:
-------
    0   ``
    1   We
    2   've
    3   known
           sense: know-v.1
           prop:  know.01
            v          * -> 3:0,  known
            ARG0       * -> 1:1,  We
            ARGM-TMP   * -> 4:1,  for six months
            ARG1       * -> 7:2,  the effect of this drug
    4   for
    5   six
           name:  DATE               5-6    six months
    6   months
    7   the
    8   effect
    9   of
    10  this
    11  drug
    12  ,
    13  and
    14  our
    15  advice
    16  to
    17  our
    18  people
    19  has
    20  been
           prop:  be.01
            v          * -> 20:0, been
            ARG1       * -> 14:2, our advice to our people
            ARG2       * -> 21:2, *PRO* not to buy the company 's stock
    21  *PRO*
    22  not
    23  to
    24  buy
           prop:  buy.01
            v          * -> 24:0, buy
            ARG0       * -> 21:0, *PRO*
            ARGM-NEG   * -> 22:0, not
            ARG1       * -> 25:2, the company 's stock
    25  the
    26  company
    27  's
    28  stock
    29  ,
    30  ''
    31  Dr.
    32  Starzl
           name:  PERSON             32-32  Starzl
    33  said
           prop:  say.01
            v          * -> 33:0, said
            ARG0       * -> 36:0, *PRO*-1 -> 31:1, Dr. Starzl
            ARG1       * -> 34:0, *T*-2 -> 1:3, We 've known for six months the effect of this drug , and our advice to
                                                our people has been *PRO* not to buy the company 's stock
            ARGM-PRD   * -> 36:2, *PRO*-1 adding that *PRO* profiting from FK - 506 would n't be ethical
    34  *T*-2
    35  ,
    36  *PRO*-1
    37  adding
           prop:  add.01
            v          * -> 37:0, adding
            ARG0       * -> 36:0, *PRO*-1 -> 31:1, Dr. Starzl
            ARG1       * -> 38:1, that *PRO* profiting from FK - 506 would n't be ethical
            LINK-PCR   * -> 36:0, *PRO*-1 -> 31:1, Dr. Starzl
                       * -> 36:0, *PRO*-1 -> 31:1, Dr. Starzl
    38  that
    39  *PRO*
    40  profiting
           sense: profit-v.1
           prop:  profit.01
            v          * -> 40:0, profiting
            ARG0       * -> 39:0, *PRO*
            ARG1       * -> 41:1, from FK - 506
    41  from
    42  FK
    43  -
    44  506
    45  would
    46  n't
    47  be
           prop:  be.01
            v          * -> 47:0, be
            ARG1       * -> 39:2, *PRO* profiting from FK - 506
            ARGM-MOD   * -> 45:0, would
            ARGM-NEG   * -> 46:0, n't
            ARG2       * -> 48:1, ethical
    48  ethical
    49  .

